Gregory R. Wagner

Based at Harvard University, Gregory R. Wagner focuses their scholarly efforts on occupational health, workplace safety, environmental lung diseases, heat-related injuries, silica exposure, injury epidemiology, occupational risk assessment, bridging the gap between theory and practice in occupational health. A representative example of their recent contribution is the study titled "AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors", which offers critical insights into the dynamics of occupational health and workplace safety. Additional work such as "NMR sample optimization and backbone assignment of a stabilized neurotensin receptor" further demonstrates their commitment to advancing knowledge in this domain.